Literature DB >> 24363067

An exploratory study on the efficacy of rat dedifferentiated fat cells (rDFATs) with a poly lactic-co-glycolic acid/hydroxylapatite (PLGA/HA) composite for bone formation in a rat calvarial defect model.

Yoshinori Shirakata1, Toshiaki Nakamura, Yukiya Shinohara, Katsuyoshi Taniyama, Kenji Sakoda, Takehiko Yoshimoto, Kazuyuki Noguchi.   

Abstract

In the last two decades, tissue-engineering approaches using scaffolds, growth factors, and cells, or their combination, have been developed for the regeneration of periodontal tissue and bone. The aim of this study was to examine the effects of rat dedifferentiated fat cells (rDFATs) with a poly lactic-co-glycolic acid/hydroxylapatite (PLGA/HA) composite on bone formation in rat calvarial defects. Twenty animals surgically received two calvarial defects (diameter, 5 mm) bilaterally in each parietal bone. The defects were treated by one of the following procedures: PLGA/HA+osteo-differentiated rDFATs implantation (PLGA/HA+rDFATs (OD)); PLGA/HA+rDFATs implantation (PLGA/HA+rDFATs); PLGA/HA implantation (PLGA/HA); no implantation as a control. The animals were euthanized at 8 weeks after the surgery for histological evaluation. The PLGA/HA composite was remarkably resorbed and the amounts of residual PLGA/HA were very slight at 8 weeks after the surgery. The PLGA/HA-implanted groups (PLGA/HA+rDFATs (OD), PLGA/HA+rDFATs and PLGA/HA) showed recovery of the original volume and contour of the defects. The newly formed bone area was significantly larger in the PLGA/HA group (42.10 ± 9.16 %) compared with the PLGA/HA+rDFATs (21.35 ± 13.49 %) and control (22.17 ± 13.08 %) groups (P < 0.05). The percentage of defect closure (DC) by new bone in the PLGA/HA+rDFATs (OD) group (83.16 ± 13.87 %) was significantly greater than that in the control group (40.61 ± 29.62 %) (P < 0.05). Furthermore, the PLGA/HA+rDFATs (OD) group showed the highest level of DC among all the groups. The present results suggest that the PLGA/HA composite is a promising scaffold and that PLGA/HA+DFATs (OD) may be effective for bone formation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24363067     DOI: 10.1007/s10856-013-5124-x

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  32 in total

1.  Dura mater stimulates human adipose-derived stromal cells to undergo bone formation in mouse calvarial defects.

Authors:  Benjamin Levi; Emily R Nelson; Shuli Li; Aaron W James; Jeong S Hyun; Daniel T Montoro; Min Lee; Jason P Glotzbach; George W Commons; Michael T Longaker
Journal:  Stem Cells       Date:  2011-08       Impact factor: 6.277

2.  Enhancement of osteogenesis by poly(lactide-co-glycolide) sponges loaded with surface-embedded hydroxyapatite particles and rhBMP-2.

Authors:  Dan Li; Chen Ye; Yang Zhu; Zhongru Gou; Changyou Gao
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2012-02-14       Impact factor: 3.368

3.  Bone healing in critical-size defects treated with bioactive glass/calcium sulfate: a histologic and histometric study in rat calvaria.

Authors:  Flávia A C Furlaneto; Maria J H Nagata; Stephen E Fucini; Tatiana M Deliberador; Tetuo Okamoto; Michel R Messora
Journal:  Clin Oral Implants Res       Date:  2007-02-13       Impact factor: 5.977

4.  Beta-TCP bone graft substitutes in a bilateral rabbit tibial defect model.

Authors:  William R Walsh; Frank Vizesi; Dean Michael; Jason Auld; Andy Langdown; Rema Oliver; Yan Yu; Hiroyuki Irie; Warwick Bruce
Journal:  Biomaterials       Date:  2008-01       Impact factor: 12.479

5.  In vivo osteogenic potential of human adipose-derived stem cells/poly lactide-co-glycolic acid constructs for bone regeneration in a rat critical-sized calvarial defect model.

Authors:  Eulsik Yoon; Sanjay Dhar; Daniel E Chun; Nareg A Gharibjanian; Gregory R D Evans
Journal:  Tissue Eng       Date:  2007-03

6.  Comparison of osteogenic potential between apatite-coated poly(lactide-co-glycolide)/hydroxyapatite particulates and Bio-Oss.

Authors:  Sang-Soo Kim; Byung-Soo Kim
Journal:  Dent Mater J       Date:  2008-05       Impact factor: 2.102

7.  Repairing critical-sized rat calvarial defects with progenitor cell-seeded acellular periosteum: a novel biomimetic scaffold.

Authors:  Scott J Rapp; Donna C Jones; Patrick Gerety; Jesse A Taylor
Journal:  Surgery       Date:  2012-09-07       Impact factor: 3.982

8.  Surface modification of biodegradable electrospun nanofiber scaffolds and their interaction with fibroblasts.

Authors:  Kwideok Park; Young Min Ju; Jun Sik Son; Kwang-Duk Ahn; Dong Keun Han
Journal:  J Biomater Sci Polym Ed       Date:  2007       Impact factor: 3.517

Review 9.  Dedifferentiated fat cells: an alternative source of adult multipotent cells from the adipose tissues.

Authors:  Jie-fei Shen; Atsunori Sugawara; Joe Yamashita; Hideo Ogura; Soh Sato
Journal:  Int J Oral Sci       Date:  2011-07       Impact factor: 6.344

10.  Periodontal tissue reaction to customized nano-hydroxyapatite block scaffold in one-wall intrabony defect: a histologic study in dogs.

Authors:  Jung-Seok Lee; Weon-Yeong Park; Jae-Kook Cha; Ui-Won Jung; Chang-Sung Kim; Yong-Keun Lee; Seong-Ho Choi
Journal:  J Periodontal Implant Sci       Date:  2012-04-30       Impact factor: 2.614

View more
  3 in total

Review 1.  Current challenges in dedifferentiated fat cells research.

Authors:  Mickey Shah; Richard L George; M Michelle Evancho-Chapman; Ge Zhang
Journal:  Organogenesis       Date:  2016-06-20       Impact factor: 2.500

2.  Shape memory polymer (SMP) scaffolds with improved self-fitting properties.

Authors:  Michaela R Pfau; Kelly G McKinzey; Abigail A Roth; Lance M Graul; Duncan J Maitland; Melissa A Grunlan
Journal:  J Mater Chem B       Date:  2021-04-15       Impact factor: 6.331

3.  Application of Green Tea Catechin for Inducing the Osteogenic Differentiation of Human Dedifferentiated Fat Cells in Vitro.

Authors:  Koji Kaida; Yoshitomo Honda; Yoshiya Hashimoto; Masahiro Tanaka; Shunsuke Baba
Journal:  Int J Mol Sci       Date:  2015-11-25       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.